REVB logo

Revelation Biosciences (REVB) Accounts Receivable

Annual Accounts Receivable

N/A

December 1, 2023

Summary

Performance

1-Year Change

-

3-Year Change

-

5-Year Change

-

15-Year Change

-

REVB Accounts Receivable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$7.67 M
REVB annual accounts receivable is currently at an all-time high

3-Year Low

-
REVB annual accounts receivable 3-year low is unknown

Earnings dates

Last Annual Earnings Report Date

Dec 1, 2023
REVB previous annual earnings announcement was published on Dec 1, 2023

Next Annual Earnings Report Date

N/A
REVB next annual earnings announcement has not yet been scheduled

OtherREVBbalance sheetmetrics:

Annual Accounts Payable

$1.36 M
REVB annual accounts payable is $1.36 million

Annual Total Assets

$12.21 M
REVB annual total assets is $12.21 million

Annual Total Liabilities

$5.56 M
REVB annual total liabilities is $5.56 million

Annual Cash & Cash Equivalents

$11.99 M
REVB annual cash & cash equivalents is $11.99 million

Accounts Receivable Formula

Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales

REVB Accounts Receivable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year--
3 y3 years--
5 y5 years--

REVB Accounts Receivable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year
5 y5-year
alltimeall time

Revelation Biosciences Accounts Receivable History

DateAnnualQuarterly
Dec 2019
$7.67 M(+11.9%)
-
Dec 2018
$6.85 M(+16.8%)
-
DateAnnualQuarterly
Dec 2017
$5.87 M(+17.9%)
-
Dec 2016
$4.98 M(+130.6%)
-
Dec 2015
$2.16 M
-

FAQ

  • What is the all time high annual accounts receivable for Revelation Biosciences?

What is the all time high annual accounts receivable for Revelation Biosciences?

Revelation Biosciences all-time high annual accounts receivable is $7.67 M